Future studies will aim to demonstrate target engagement of HGF/MET signaling and treatment effects in induced pluripotent stem cell-derived motor neurons from ALS patients as a surrogate for activity in human tissues. The gene discussed is MET; the disease is amyotrophic lateral sclerosis.